FAQs​

There are several online resources to learn more about MM and your options, from advocacy groups to research foundations. If you’d like to learn more, please take a look at some of the resources listed below.

Black Health Matters

HealthTree Foundation for Multiple Myeloma

International Myeloma Foundation

Myeloma Action Month

Multiple Myeloma Research Foundation

Myeloma UK

Myeloma Made Simple

A clinical study is a research study conducted in human volunteers to answer specific health questions. Interventional studies determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Clinical studies are also called clinical trials.

The LINKER studies are clinical research studies for people with relapsed or refractory MM and newly diagnosed MM respectively. The LINKER studies seek to evaluate the safety, tolerability, and efficacy of an investigational drug in treating MM.

Eligibility will differ based on which LINKER study you join. Learn more about the LINKER studies to find out if you may be eligible.
Learn more

If you join the study, there are certain things you will be expected to do. This includes attending study visits and undergoing certain assessments and procedures including bone marrow biopsies and imaging scans. The length of your participation will depend on your response to the study drugs. You will be asked to complete study visits once a week to once a month.

The length of your participation will depend on several factors, including which study you participate in, your response to the study drug.

You may benefit from additional check-ups on top of your regular care, and you may have access to MM specialists. There is no guarantee that you will receive a medical benefit from participating in this study. Your condition may get better, stay the same, or may even get worse.

As with all drugs, there are possible risks when taking them. You will be provided with an Informed Consent Form that will explain the risks that have been seen in other clinical studies researching the investigational study drug. It is also possible that the drug may affect you in unknown ways. If you should experience any changes in your health, however unrelated you think they may be, you should tell your study doctor and study team.

The LINKER studies are taking place at study centers worldwide. Learn more about the LINKER studies to find out which study center is closest to you.
Learn more

If you have more questions about the LINKER studies, please contact the site closest to you. Learn more about the LINKER studies to find out which site is closest to you.
Learn more